Clinical Trials Logo

Hysterectomy clinical trials

View clinical trials related to Hysterectomy.

Filter by:

NCT ID: NCT03363425 Recruiting - Hysterectomy Clinical Trials

Effect of Perioperative iv Dexmedetomidine vs. Lidocaine on Postoperative Pain, Analgesic Consumption and Recovery After Abdominal Gynaecological Surgery

Start date: November 14, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Postoperative pain continues to be inadequately managed and is the most common reason for the delay in discharge and unplanned hospital admission after surgery. Opioids remain the mainstay for postoperative analgesia. However, there is a continuous search for adjuvant therapies to reduce the doses of opioids and their related adverse effects, and extend the use of non-opioid analgesia for acute pain after abdominal surgery, thereby improving patient recovery. Currently there are no clinical trials that investigate the effect of intravenous lidocaine vs dexmedetomidine on postoperative pain, analgesic consumption and bowel function of patients undergoing abdominal gynaecological surgery. Purpose of this prospective double blind randomised clinical trial is the investigation of the effect of perioperative intravenous infusion of lidocaine vs dexmedetomidine vs placebo (Normal Saline 0,9%) on analgesic parameters and functional recovery of patients undergoing abdominal gynaecological surgery.

NCT ID: NCT03347409 Completed - Surgery Clinical Trials

Validation of an ERAS Protocol in Gynecological Surgery

ERASGYNBS001
Start date: June 14, 2017
Phase: N/A
Study type: Interventional

Validation of ERAS interventional measures in elective gynecological surgery, for benign either malignant pathology.

NCT ID: NCT03341533 Completed - Pain, Postoperative Clinical Trials

Abdominal Ice Packs for Pain Control and Reduction of Narcotic Use Following Laparoscopic Hysterectomy

Start date: January 12, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of using ice packs on the abdomen immediately after laparoscopic hysterectomy surgery on pain control and narcotic pain medication use.

NCT ID: NCT03302208 Completed - Hysterectomy Clinical Trials

Preoperative Oral Pregabalin Effect on Inhalational Anesthetic Requirements ln Hysterectomy Under General Anesthesia

Start date: June 29, 2017
Phase: Phase 3
Study type: Interventional

In this study the investigators hypothesized that preoperative pregabalin tablet (150 mg orally ) may be effective in reducing intraoperative isoflurane requirements needed to maintain intraoperative hemodynamics within ± 20% of baseline measurement and/or attenuates hemodynamic response to endotracheal intubation in female patients ASA I or II , aged 18-60 years, schedule for elective abdominal hysterectomy surgery under general anesthesia.

NCT ID: NCT03294343 Recruiting - Hysterectomy Clinical Trials

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Based on studies of "Inherited Susceptible Genes Among Epithelial Ovarian Cancer" (NCT03015376, clinicaltrials.gov) and "Cohort Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer" (NCT03291106, clinicaltrials.gov), we provide risk-reducing surgeries of salpingo-oophorectomy with/without hysterectomy for healthy carriers with mutation genes of hereditary ovarian cancer, which is defined ovarian cancer with relevant pathogenic mutations.

NCT ID: NCT03283436 Completed - Hysterectomy Clinical Trials

RCT Superior Hypogastric Block During LH

Start date: January 18, 2018
Phase: Phase 4
Study type: Interventional

The goal of this study is to assess the efficacy of a superior hypogastric plexus block (SHPB) for pain relief following a laparoscopic hysterectomy.

NCT ID: NCT03250507 Completed - Hysterectomy Clinical Trials

Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy

Start date: March 13, 2017
Phase: Phase 4
Study type: Interventional

The goal of this study is to evaluate the effectiveness of different formulations of bupivacaine infiltrated into the transversus abdominis plane (TAP) on post-operative pain management after open abdominal hysterectomy.

NCT ID: NCT03231683 Completed - Anesthesia Clinical Trials

Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy

Start date: March 2014
Phase: Phase 2
Study type: Interventional

The investigators want to investigate the effect of low dose S+ ketamine compared to placebo on cumulative morphine consumption at 24 hours in 90 women undergoing open abdominal hysterectomy with remifentanil-propofol target controlled infusion (TCI) in KK Women's and Children's Hospital. The secondary aims are to investigate the use of low dose S+ ketamine on the incidence of nausea, vomiting, pruritus (opioid side effect), sedation score and psycho mimetic assessment compared to placebo group. The investigators propose to conduct a double blinded, randomized controlled study in women undergoing open abdominal hysterectomy with remifentanil-propofol TCI. (1) Treatment Group: intravenous ketamine 0.5 mg/kg at the beginning and 0.5 mg/kg 20 minutes before extubation. (2) Control Group: intravenous normal saline (as placebo) at the beginning and 20 minutes before extubation.

NCT ID: NCT03187327 Completed - Hysterectomy Clinical Trials

Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology

FPS
Start date: September 2013
Phase: N/A
Study type: Observational

In this prospective study, patients who underwent vaginal hysterectomy with salpingectomy or salpingo-oophorectomy were included. The objective of this study is to assess the feasibility of prophylactic salpingectomy during vaginal hysterectomy for benign pathology and the prevalence of occult tubal lesions. The hypothesis is that prophylactic salpingectomy during vaginal hysterectomy for benign pathology present a low failure rate and it makes it possible to avoid the appearance of a certain number of ovarian cancers. The prevalence of bilateral salpingectomy with or without ovariectomy and the prevalence of histopathological and immunohistochemical (p53 expression) abnormalities were evaluated.

NCT ID: NCT03123315 Withdrawn - Hysterectomy Clinical Trials

Optimization of Ureterolysis During Hysterectomy

Start date: April 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to improve the safety of surgery to remove a uterus (a hysterectomy) by better understanding where a patient's ureters lie.